Aroon Lueangniyomkul

A Randomized Trial Comparing Plasma Drug Concentrations and Efficacies between 2 Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Regimens in HIV‐Infected Patients Receiving Rifampicin: The N₂R Study

Weerawat Manosuthi, Somnuek Sungkanuparph, Preecha Tantanathip et al. · Clinical Infectious Diseases · 2009 · 114 citations · Full text

Standard‐dose efavirenz <i>vs.</i> standard‐dose nevirapine in antiretroviral regimens among HIV‐1 and tuberculosis co‐infected patients who received rifampicin

Weerawat Manosuthi, Wiroj Mankatitham, Aroon Lueangniyomkul et al. · HIV Medicine · 2008 · 53 citations · Full text

Time to Initiate Antiretroviral Therapy Between 4 Weeks and 12 Weeks of Tuberculosis Treatment in HIV-Infected Patients

Weerawat Manosuthi, Wiroj Mankatitham, Aroon Lueangniyomkul et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2012 · 51 citations

Impact of Pharmacogenetic Markers of<i>CYP2B6</i>, Clinical Factors, and Drug-Drug Interaction on Efavirenz Concentrations in HIV/Tuberculosis-Coinfected Patients

Weerawat Manosuthi, Chonlaphat Sukasem, Aroon Lueangniyomkul et al. · Antimicrobial Agents and Chemotherapy · 2012 · 40 citations · Full text

Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome

Weerawat Manosuthi, Hong‐Van Tieu, Wiroj Mankatitham et al. · AIDS · 2009 · 38 citations